Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.
Li-Tzy Wu, George E Woody, Chongming Yang, Jih-Heng Li, Dan G Blazer
Substance abuse and rehabilitation April 1, 2011 DOI: 10.2147/sar.s17192 via PubMed
Summary
AI-generated from the abstractBetween 2006 and 2008, past-year use of Salvia divinorum among US residents aged 12 or older rose from 0.7% to 1.3%, an 83% increase. Users were typically 18–25 years old, male, white or multiracial, and living in large metropolitan areas. Salvia use was especially common among people who also used other drugs: 53.7% of recent users had used LSD, 30.1% ecstasy, 24.2% heroin, 22.4% PCP, and 17.5% cocaine. Polydrug use was the strongest predictor of both recent and former salvia use. An estimated 43% of past-year salvia users had an illicit or nonmedical drug-use disorder, compared with 2.5% of nonusers. Even after adjusting for other drug use, salvia users had higher odds of depression and substance-use disorders.
Study at a glance
| Characteristics | Cross-sectional survey analysis Peer reviewed |
|---|---|
| Sample size | 166,453 |
| Population | Noninstitutionalized US residents aged 12 or older |
| Topics | Addiction Salvia divinorum |
| Keywords | Salvia divinorum use Substance-use disorder Substance use issues Polydrug use |
| Citations | 40 |
| Key finding | Salvia divinorum use increased from 0.7% to 1.3% between 2006 and 2008, was strongly associated with polydrug use, and 43% of past-year users had a drug-use disorder. |
Abstract
CONTEXT: Media and scientific reports have indicated an increase in recreational use of Salvia divinorum. Epidemiological data are lacking on the trends, prevalence, and correlates of S. divinorum use in large representative samples, as well as the extent of substance use and mental health problems among S. divinorum users. OBJECTIVE: To examine the national trend in prevalence of S. divinorum use and to identify sociodemographic, behavioral, mental health, and substance-use profiles of recent (past-year) and former users of S. divinorum. DESIGN: Analyses of public-use data files from the 2006-2008 United States National Surveys on Drug Use and Health (N = 166,453). SETTING: Noninstitutionalized individuals aged 12 years or older were interviewed in their places of residence. MAIN MEASURES: Substance use, S. divinorum, self-reported substance use disorders, criminality, depression, and mental health treatment were assessed by standardized survey questions administered by the audio computer-assisted self-interviewing method. RESULTS: Among survey respondents, lifetime prevalence of S. divinorum use had increased from 0.7% in 2006 to 1.3% in 2008 (an 83% increase). S. divinorum use was associated with ages 18-25 years, male gender, white or multiple race, residence of large metropolitan areas, arrests for criminal activities, and depression. S. divinorum use was particularly common among recent drug users, including users of lysergic acid diethylamide (53.7%), ecstasy (30.1%), heroin (24.2%), phencyclidine (22.4%), and cocaine (17.5%). Adjusted multinomial logistic analyses indicated polydrug use as the strongest determinant for recent and former S. divinorum use. An estimated 43.0% of past-year S. divinorum users and 28.9% of former S. divinorum users had an illicit or nonmedical drug-use disorder compared with 2.5% of nonusers. Adjusted logistic regression analyses showed that recent and former S. divinorum users had greater odds of having past-year depression and a substance-use disorder (alcohol or drugs) than past-year alcohol or drug users who did not use S. divinorum. CONCLUSION: S. divinorum use is prevalent among recent or active drug users who have used other hallucinogens or stimulants. The high prevalence of substance use disorders among recent S. divinorum users emphasizes the need to study health risks of drug interactions.